nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ABCB1—lung cancer	0.105	1	CbGaD
Doxepin—ORM1—Gefitinib—lung cancer	0.0773	0.154	CbGbCtD
Doxepin—ORM1—Erlotinib—lung cancer	0.0457	0.0911	CbGbCtD
Doxepin—CYP2C19—Gefitinib—lung cancer	0.0211	0.042	CbGbCtD
Doxepin—CYP2C19—Teniposide—lung cancer	0.0204	0.0408	CbGbCtD
Doxepin—ABCB1—Topotecan—lung cancer	0.0186	0.0371	CbGbCtD
Doxepin—CYP2C9—Gefitinib—lung cancer	0.0175	0.035	CbGbCtD
Doxepin—ABCB1—Gefitinib—lung cancer	0.017	0.0339	CbGbCtD
Doxepin—CYP2C9—Teniposide—lung cancer	0.017	0.0339	CbGbCtD
Doxepin—CYP2D6—Gefitinib—lung cancer	0.016	0.032	CbGbCtD
Doxepin—ABCB1—Vinorelbine—lung cancer	0.0131	0.0261	CbGbCtD
Doxepin—CYP2D6—Vinorelbine—lung cancer	0.0123	0.0246	CbGbCtD
Doxepin—CYP1A2—Erlotinib—lung cancer	0.0115	0.0229	CbGbCtD
Doxepin—CYP3A4—Topotecan—lung cancer	0.0111	0.0222	CbGbCtD
Doxepin—ABCB1—Crizotinib—lung cancer	0.0104	0.0208	CbGbCtD
Doxepin—CYP3A4—Gefitinib—lung cancer	0.0102	0.0203	CbGbCtD
Doxepin—ABCB1—Gemcitabine—lung cancer	0.0102	0.0203	CbGbCtD
Doxepin—ABCB1—Erlotinib—lung cancer	0.0101	0.0201	CbGbCtD
Doxepin—CYP3A4—Teniposide—lung cancer	0.00988	0.0197	CbGbCtD
Doxepin—CYP2C9—Paclitaxel—lung cancer	0.00949	0.0189	CbGbCtD
Doxepin—CYP2D6—Erlotinib—lung cancer	0.00948	0.0189	CbGbCtD
Doxepin—ABCB1—Paclitaxel—lung cancer	0.00921	0.0184	CbGbCtD
Doxepin—ABCB1—Irinotecan—lung cancer	0.00908	0.0181	CbGbCtD
Doxepin—CYP1A2—Etoposide—lung cancer	0.00832	0.0166	CbGbCtD
Doxepin—ABCB1—Vinblastine—lung cancer	0.00808	0.0161	CbGbCtD
Doxepin—CYP3A4—Vinorelbine—lung cancer	0.00785	0.0157	CbGbCtD
Doxepin—CYP2C9—Cisplatin—lung cancer	0.00763	0.0152	CbGbCtD
Doxepin—CYP2D6—Vinblastine—lung cancer	0.00761	0.0152	CbGbCtD
Doxepin—ABCB1—Cisplatin—lung cancer	0.00741	0.0148	CbGbCtD
Doxepin—ABCB1—Etoposide—lung cancer	0.00728	0.0145	CbGbCtD
Doxepin—ABCB1—Docetaxel—lung cancer	0.00666	0.0133	CbGbCtD
Doxepin—CYP3A4—Crizotinib—lung cancer	0.00625	0.0125	CbGbCtD
Doxepin—HTR2A—phrenic nerve—lung cancer	0.00616	0.21	CbGeAlD
Doxepin—CYP3A4—Erlotinib—lung cancer	0.00603	0.012	CbGbCtD
Doxepin—CYP3A4—Paclitaxel—lung cancer	0.00552	0.011	CbGbCtD
Doxepin—CYP3A4—Irinotecan—lung cancer	0.00544	0.0109	CbGbCtD
Doxepin—ABCB1—Doxorubicin—lung cancer	0.00496	0.00989	CbGbCtD
Doxepin—CYP3A4—Vinblastine—lung cancer	0.00484	0.00965	CbGbCtD
Doxepin—ABCB1—Methotrexate—lung cancer	0.00481	0.00959	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—lung cancer	0.00468	0.00932	CbGbCtD
Doxepin—CYP3A4—Etoposide—lung cancer	0.00436	0.00869	CbGbCtD
Doxepin—CYP3A4—Docetaxel—lung cancer	0.00399	0.00795	CbGbCtD
Doxepin—CYP3A4—Doxorubicin—lung cancer	0.00297	0.00593	CbGbCtD
Doxepin—HTR2A—pulmonary artery—lung cancer	0.00224	0.0762	CbGeAlD
Doxepin—HRH4—bone marrow—lung cancer	0.00166	0.0564	CbGeAlD
Doxepin—CHRM5—epithelium—lung cancer	0.000947	0.0323	CbGeAlD
Doxepin—ADRA1D—epithelium—lung cancer	0.000846	0.0288	CbGeAlD
Doxepin—HRH2—cardiac atrium—lung cancer	0.000823	0.0281	CbGeAlD
Doxepin—SLC6A4—respiratory system—lung cancer	0.000711	0.0242	CbGeAlD
Doxepin—CYP2C9—mammary gland—lung cancer	0.000685	0.0234	CbGeAlD
Doxepin—HRH2—lung—lung cancer	0.00063	0.0215	CbGeAlD
Doxepin—SLC6A2—respiratory system—lung cancer	0.000626	0.0213	CbGeAlD
Doxepin—DRD2—respiratory system—lung cancer	0.00057	0.0194	CbGeAlD
Doxepin—CHRM1—trachea—lung cancer	0.000523	0.0178	CbGeAlD
Doxepin—ORM1—bone marrow—lung cancer	0.000489	0.0167	CbGeAlD
Doxepin—ADRA1A—epithelium—lung cancer	0.000486	0.0166	CbGeAlD
Doxepin—CYP1A2—respiratory system—lung cancer	0.000481	0.0164	CbGeAlD
Doxepin—ADRA2C—bronchus—lung cancer	0.000456	0.0155	CbGeAlD
Doxepin—HRH1—respiratory system—lung cancer	0.00045	0.0153	CbGeAlD
Doxepin—ORM1—lung—lung cancer	0.000443	0.0151	CbGeAlD
Doxepin—HRH2—lymph node—lung cancer	0.000431	0.0147	CbGeAlD
Doxepin—ADRA2C—trachea—lung cancer	0.00041	0.014	CbGeAlD
Doxepin—KCNH2—cardiac atrium—lung cancer	0.00039	0.0133	CbGeAlD
Doxepin—ADRA2C—cardiac atrium—lung cancer	0.000385	0.0131	CbGeAlD
Doxepin—SLC6A4—lung—lung cancer	0.000377	0.0129	CbGeAlD
Doxepin—HRH1—epithelium—lung cancer	0.000376	0.0128	CbGeAlD
Doxepin—HTR2A—respiratory system—lung cancer	0.000376	0.0128	CbGeAlD
Doxepin—CHRM1—lung—lung cancer	0.000376	0.0128	CbGeAlD
Doxepin—HTR2B—lung—lung cancer	0.000374	0.0127	CbGeAlD
Doxepin—ADRA2A—bronchus—lung cancer	0.000364	0.0124	CbGeAlD
Doxepin—HRH1—trachea—lung cancer	0.000333	0.0113	CbGeAlD
Doxepin—SLC6A2—lung—lung cancer	0.000332	0.0113	CbGeAlD
Doxepin—KCNH2—bone marrow—lung cancer	0.000329	0.0112	CbGeAlD
Doxepin—ADRA2A—trachea—lung cancer	0.000327	0.0111	CbGeAlD
Doxepin—HTR2A—epithelium—lung cancer	0.000314	0.0107	CbGeAlD
Doxepin—ADRA2A—cardiac atrium—lung cancer	0.000307	0.0105	CbGeAlD
Doxepin—ORM1—lymph node—lung cancer	0.000303	0.0103	CbGeAlD
Doxepin—DRD2—lung—lung cancer	0.000303	0.0103	CbGeAlD
Doxepin—Clomipramine—GSTP1—lung cancer	0.000298	0.146	CrCbGaD
Doxepin—ADRA2C—lung—lung cancer	0.000294	0.01	CbGeAlD
Doxepin—HTR2A—trachea—lung cancer	0.000278	0.00947	CbGeAlD
Doxepin—HTR2B—lymph node—lung cancer	0.000256	0.00872	CbGeAlD
Doxepin—CYP1A2—lung—lung cancer	0.000255	0.00871	CbGeAlD
Doxepin—ABCB1—respiratory system—lung cancer	0.000246	0.0084	CbGeAlD
Doxepin—HRH1—lung—lung cancer	0.000239	0.00815	CbGeAlD
Doxepin—ADRA2A—lung—lung cancer	0.000235	0.008	CbGeAlD
Doxepin—SLC6A2—lymph node—lung cancer	0.000227	0.00775	CbGeAlD
Doxepin—ABCB1—epithelium—lung cancer	0.000206	0.00702	CbGeAlD
Doxepin—KCNH2—lymph node—lung cancer	0.000204	0.00695	CbGeAlD
Doxepin—ADRA2C—lymph node—lung cancer	0.000201	0.00686	CbGeAlD
Doxepin—HTR2A—lung—lung cancer	0.0002	0.00681	CbGeAlD
Doxepin—ABCB1—trachea—lung cancer	0.000182	0.00621	CbGeAlD
Doxepin—Desipramine—CYP2A6—lung cancer	0.000173	0.0851	CrCbGaD
Doxepin—HRH1—lymph node—lung cancer	0.000164	0.00557	CbGeAlD
Doxepin—ADRA2A—lymph node—lung cancer	0.000161	0.00547	CbGeAlD
Doxepin—Nortriptyline—CYP2E1—lung cancer	0.000149	0.0734	CrCbGaD
Doxepin—Oxcarbazepine—ALB—lung cancer	0.000146	0.0718	CrCbGaD
Doxepin—ABCB1—bone marrow—lung cancer	0.000144	0.00492	CbGeAlD
Doxepin—ABCB1—lung—lung cancer	0.000131	0.00446	CbGeAlD
Doxepin—Orphenadrine—CYP2E1—lung cancer	0.00013	0.0642	CrCbGaD
Doxepin—Desipramine—CYP2E1—lung cancer	0.000123	0.0604	CrCbGaD
Doxepin—Thiothixene—ALB—lung cancer	0.000106	0.0522	CrCbGaD
Doxepin—Imipramine—CYP2E1—lung cancer	0.000104	0.0512	CrCbGaD
Doxepin—Amitriptyline—CYP2E1—lung cancer	0.000104	0.0509	CrCbGaD
Doxepin—ABCB1—lymph node—lung cancer	8.95e-05	0.00305	CbGeAlD
Doxepin—Clomipramine—ALB—lung cancer	8.39e-05	0.0413	CrCbGaD
Doxepin—Hepatitis—Methotrexate—lung cancer	8.27e-05	0.000358	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—lung cancer	8.27e-05	0.000358	CcSEcCtD
Doxepin—Asthenia—Gemcitabine—lung cancer	8.24e-05	0.000357	CcSEcCtD
Doxepin—Constipation—Paclitaxel—lung cancer	8.22e-05	0.000356	CcSEcCtD
Doxepin—Pain—Paclitaxel—lung cancer	8.22e-05	0.000356	CcSEcCtD
Doxepin—Confusional state—Docetaxel—lung cancer	8.22e-05	0.000356	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—lung cancer	8.21e-05	0.000356	CcSEcCtD
Doxepin—Nortriptyline—ALB—lung cancer	8.19e-05	0.0403	CrCbGaD
Doxepin—Urinary tract disorder—Methotrexate—lung cancer	8.17e-05	0.000354	CcSEcCtD
Doxepin—Oedema—Docetaxel—lung cancer	8.15e-05	0.000353	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—lung cancer	8.14e-05	0.000353	CcSEcCtD
Doxepin—Pruritus—Gemcitabine—lung cancer	8.13e-05	0.000352	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—lung cancer	8.11e-05	0.000351	CcSEcCtD
Doxepin—Infection—Docetaxel—lung cancer	8.1e-05	0.000351	CcSEcCtD
Doxepin—Feeling abnormal—Etoposide—lung cancer	8.08e-05	0.00035	CcSEcCtD
Doxepin—Diarrhoea—Irinotecan—lung cancer	8.07e-05	0.000349	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—lung cancer	8.02e-05	0.000348	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—lung cancer	8.02e-05	0.000347	CcSEcCtD
Doxepin—Shock—Docetaxel—lung cancer	8.02e-05	0.000347	CcSEcCtD
Doxepin—Clomipramine—ABCB1—lung cancer	8e-05	0.0394	CrCbGaD
Doxepin—Nervous system disorder—Docetaxel—lung cancer	7.99e-05	0.000346	CcSEcCtD
Doxepin—Thrombocytopenia—Docetaxel—lung cancer	7.98e-05	0.000346	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—lung cancer	7.98e-05	0.000345	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—lung cancer	7.98e-05	0.000345	CcSEcCtD
Doxepin—Infestation—Doxorubicin—lung cancer	7.98e-05	0.000345	CcSEcCtD
Doxepin—Chlorprothixene—ABCB1—lung cancer	7.97e-05	0.0392	CrCbGaD
Doxepin—Tachycardia—Docetaxel—lung cancer	7.96e-05	0.000345	CcSEcCtD
Doxepin—Feeling abnormal—Paclitaxel—lung cancer	7.93e-05	0.000343	CcSEcCtD
Doxepin—Skin disorder—Docetaxel—lung cancer	7.92e-05	0.000343	CcSEcCtD
Doxepin—Hypersensitivity—Cisplatin—lung cancer	7.89e-05	0.000342	CcSEcCtD
Doxepin—Gastrointestinal pain—Paclitaxel—lung cancer	7.86e-05	0.000341	CcSEcCtD
Doxepin—Diarrhoea—Gemcitabine—lung cancer	7.86e-05	0.00034	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—lung cancer	7.82e-05	0.000339	CcSEcCtD
Doxepin—Dizziness—Irinotecan—lung cancer	7.8e-05	0.000338	CcSEcCtD
Doxepin—Urticaria—Etoposide—lung cancer	7.79e-05	0.000338	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—lung cancer	7.78e-05	0.000337	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—lung cancer	7.78e-05	0.000337	CcSEcCtD
Doxepin—Anorexia—Docetaxel—lung cancer	7.77e-05	0.000337	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—lung cancer	7.75e-05	0.000336	CcSEcCtD
Doxepin—Body temperature increased—Etoposide—lung cancer	7.75e-05	0.000336	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—lung cancer	7.75e-05	0.000336	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—lung cancer	7.73e-05	0.000335	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—lung cancer	7.71e-05	0.000334	CcSEcCtD
Doxepin—Asthenia—Cisplatin—lung cancer	7.68e-05	0.000333	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—lung cancer	7.68e-05	0.000332	CcSEcCtD
Doxepin—Sweating—Doxorubicin—lung cancer	7.65e-05	0.000331	CcSEcCtD
Doxepin—Urticaria—Paclitaxel—lung cancer	7.64e-05	0.000331	CcSEcCtD
Doxepin—Hypotension—Docetaxel—lung cancer	7.62e-05	0.00033	CcSEcCtD
Doxepin—Abdominal pain—Paclitaxel—lung cancer	7.6e-05	0.000329	CcSEcCtD
Doxepin—Body temperature increased—Paclitaxel—lung cancer	7.6e-05	0.000329	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—lung cancer	7.54e-05	0.000327	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—lung cancer	7.5e-05	0.000325	CcSEcCtD
Doxepin—Vomiting—Irinotecan—lung cancer	7.5e-05	0.000325	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—lung cancer	7.48e-05	0.000324	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—lung cancer	7.47e-05	0.000324	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—lung cancer	7.45e-05	0.000323	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—lung cancer	7.44e-05	0.000322	CcSEcCtD
Doxepin—Rash—Irinotecan—lung cancer	7.44e-05	0.000322	CcSEcCtD
Doxepin—Dermatitis—Irinotecan—lung cancer	7.43e-05	0.000322	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Docetaxel—lung cancer	7.43e-05	0.000322	CcSEcCtD
Doxepin—Chills—Methotrexate—lung cancer	7.42e-05	0.000321	CcSEcCtD
Doxepin—Headache—Irinotecan—lung cancer	7.39e-05	0.00032	CcSEcCtD
Doxepin—Insomnia—Docetaxel—lung cancer	7.37e-05	0.000319	CcSEcCtD
Doxepin—Trimipramine—ABCB1—lung cancer	7.36e-05	0.0362	CrCbGaD
Doxepin—Diarrhoea—Cisplatin—lung cancer	7.33e-05	0.000317	CcSEcCtD
Doxepin—Paraesthesia—Docetaxel—lung cancer	7.32e-05	0.000317	CcSEcCtD
Doxepin—Alopecia—Methotrexate—lung cancer	7.31e-05	0.000317	CcSEcCtD
Doxepin—Vomiting—Gemcitabine—lung cancer	7.3e-05	0.000316	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—lung cancer	7.29e-05	0.000316	CcSEcCtD
Doxepin—Dyspnoea—Docetaxel—lung cancer	7.27e-05	0.000315	CcSEcCtD
Doxepin—Somnolence—Docetaxel—lung cancer	7.25e-05	0.000314	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—lung cancer	7.25e-05	0.000314	CcSEcCtD
Doxepin—Rash—Gemcitabine—lung cancer	7.24e-05	0.000314	CcSEcCtD
Doxepin—Dermatitis—Gemcitabine—lung cancer	7.24e-05	0.000313	CcSEcCtD
Doxepin—Hypersensitivity—Etoposide—lung cancer	7.23e-05	0.000313	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—lung cancer	7.2e-05	0.000312	CcSEcCtD
Doxepin—Erythema—Methotrexate—lung cancer	7.2e-05	0.000312	CcSEcCtD
Doxepin—Headache—Gemcitabine—lung cancer	7.2e-05	0.000312	CcSEcCtD
Doxepin—Dyspepsia—Docetaxel—lung cancer	7.18e-05	0.000311	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—lung cancer	7.16e-05	0.00031	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—lung cancer	7.13e-05	0.000309	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—lung cancer	7.11e-05	0.000308	CcSEcCtD
Doxepin—Promethazine—ABCB1—lung cancer	7.09e-05	0.0349	CrCbGaD
Doxepin—Decreased appetite—Docetaxel—lung cancer	7.09e-05	0.000307	CcSEcCtD
Doxepin—Hypersensitivity—Paclitaxel—lung cancer	7.09e-05	0.000307	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—lung cancer	7.07e-05	0.000306	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—lung cancer	7.05e-05	0.000306	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—lung cancer	7.05e-05	0.000305	CcSEcCtD
Doxepin—Gastrointestinal disorder—Docetaxel—lung cancer	7.04e-05	0.000305	CcSEcCtD
Doxepin—Asthenia—Etoposide—lung cancer	7.04e-05	0.000305	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—lung cancer	7.04e-05	0.000305	CcSEcCtD
Doxepin—Fatigue—Docetaxel—lung cancer	7.03e-05	0.000304	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—lung cancer	7.02e-05	0.000304	CcSEcCtD
Doxepin—Nausea—Irinotecan—lung cancer	7e-05	0.000303	CcSEcCtD
Doxepin—Constipation—Docetaxel—lung cancer	6.97e-05	0.000302	CcSEcCtD
Doxepin—Pain—Docetaxel—lung cancer	6.97e-05	0.000302	CcSEcCtD
Doxepin—Back pain—Methotrexate—lung cancer	6.96e-05	0.000302	CcSEcCtD
Doxepin—Pruritus—Etoposide—lung cancer	6.94e-05	0.000301	CcSEcCtD
Doxepin—Asthenia—Paclitaxel—lung cancer	6.9e-05	0.000299	CcSEcCtD
Doxepin—Nausea—Gemcitabine—lung cancer	6.82e-05	0.000296	CcSEcCtD
Doxepin—Vomiting—Cisplatin—lung cancer	6.81e-05	0.000295	CcSEcCtD
Doxepin—Pruritus—Paclitaxel—lung cancer	6.8e-05	0.000295	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—lung cancer	6.79e-05	0.000294	CcSEcCtD
Doxepin—Rash—Cisplatin—lung cancer	6.75e-05	0.000292	CcSEcCtD
Doxepin—Dermatitis—Cisplatin—lung cancer	6.75e-05	0.000292	CcSEcCtD
Doxepin—Feeling abnormal—Docetaxel—lung cancer	6.72e-05	0.000291	CcSEcCtD
Doxepin—Diarrhoea—Etoposide—lung cancer	6.71e-05	0.000291	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—lung cancer	6.69e-05	0.00029	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—lung cancer	6.68e-05	0.000289	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—lung cancer	6.68e-05	0.000289	CcSEcCtD
Doxepin—Gastrointestinal pain—Docetaxel—lung cancer	6.67e-05	0.000289	CcSEcCtD
Doxepin—Anaemia—Methotrexate—lung cancer	6.65e-05	0.000288	CcSEcCtD
Doxepin—Flushing—Doxorubicin—lung cancer	6.65e-05	0.000288	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—lung cancer	6.65e-05	0.000288	CcSEcCtD
Doxepin—Diarrhoea—Paclitaxel—lung cancer	6.58e-05	0.000285	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—lung cancer	6.5e-05	0.000281	CcSEcCtD
Doxepin—Malaise—Methotrexate—lung cancer	6.49e-05	0.000281	CcSEcCtD
Doxepin—Dizziness—Etoposide—lung cancer	6.49e-05	0.000281	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—lung cancer	6.47e-05	0.00028	CcSEcCtD
Doxepin—Vertigo—Methotrexate—lung cancer	6.47e-05	0.00028	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—lung cancer	6.45e-05	0.00028	CcSEcCtD
Doxepin—Abdominal pain—Docetaxel—lung cancer	6.44e-05	0.000279	CcSEcCtD
Doxepin—Body temperature increased—Docetaxel—lung cancer	6.44e-05	0.000279	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—lung cancer	6.44e-05	0.000279	CcSEcCtD
Doxepin—Desipramine—ABCB1—lung cancer	6.44e-05	0.0317	CrCbGaD
Doxepin—Chills—Doxorubicin—lung cancer	6.43e-05	0.000278	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—lung cancer	6.4e-05	0.000277	CcSEcCtD
Doxepin—Dizziness—Paclitaxel—lung cancer	6.36e-05	0.000275	CcSEcCtD
Doxepin—Nausea—Cisplatin—lung cancer	6.36e-05	0.000275	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—lung cancer	6.33e-05	0.000274	CcSEcCtD
Doxepin—Cough—Methotrexate—lung cancer	6.28e-05	0.000272	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—lung cancer	6.27e-05	0.000272	CcSEcCtD
Doxepin—Convulsion—Methotrexate—lung cancer	6.24e-05	0.00027	CcSEcCtD
Doxepin—Vomiting—Etoposide—lung cancer	6.24e-05	0.00027	CcSEcCtD
Doxepin—Erythema—Doxorubicin—lung cancer	6.23e-05	0.00027	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—lung cancer	6.23e-05	0.00027	CcSEcCtD
Doxepin—Rash—Etoposide—lung cancer	6.19e-05	0.000268	CcSEcCtD
Doxepin—Dermatitis—Etoposide—lung cancer	6.18e-05	0.000268	CcSEcCtD
Doxepin—Headache—Etoposide—lung cancer	6.15e-05	0.000266	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—lung cancer	6.14e-05	0.000266	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—lung cancer	6.13e-05	0.000265	CcSEcCtD
Doxepin—Chest pain—Methotrexate—lung cancer	6.13e-05	0.000265	CcSEcCtD
Doxepin—Myalgia—Methotrexate—lung cancer	6.13e-05	0.000265	CcSEcCtD
Doxepin—Tension—Doxorubicin—lung cancer	6.12e-05	0.000265	CcSEcCtD
Doxepin—Vomiting—Paclitaxel—lung cancer	6.12e-05	0.000265	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—lung cancer	6.1e-05	0.000264	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.09e-05	0.000264	CcSEcCtD
Doxepin—Rash—Paclitaxel—lung cancer	6.06e-05	0.000263	CcSEcCtD
Doxepin—Dermatitis—Paclitaxel—lung cancer	6.06e-05	0.000262	CcSEcCtD
Doxepin—Discomfort—Methotrexate—lung cancer	6.06e-05	0.000262	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—lung cancer	6.05e-05	0.000262	CcSEcCtD
Doxepin—Back pain—Doxorubicin—lung cancer	6.03e-05	0.000261	CcSEcCtD
Doxepin—Headache—Paclitaxel—lung cancer	6.03e-05	0.000261	CcSEcCtD
Doxepin—Hypersensitivity—Docetaxel—lung cancer	6.01e-05	0.00026	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—lung cancer	5.99e-05	0.00026	CcSEcCtD
Doxepin—Confusional state—Methotrexate—lung cancer	5.92e-05	0.000257	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—lung cancer	5.88e-05	0.000254	CcSEcCtD
Doxepin—Asthenia—Docetaxel—lung cancer	5.85e-05	0.000253	CcSEcCtD
Doxepin—Infection—Methotrexate—lung cancer	5.84e-05	0.000253	CcSEcCtD
Doxepin—Nausea—Etoposide—lung cancer	5.83e-05	0.000252	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—lung cancer	5.78e-05	0.000251	CcSEcCtD
Doxepin—Pruritus—Docetaxel—lung cancer	5.77e-05	0.00025	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—lung cancer	5.76e-05	0.00025	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—lung cancer	5.76e-05	0.00025	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—lung cancer	5.75e-05	0.000249	CcSEcCtD
Doxepin—Agitation—Doxorubicin—lung cancer	5.73e-05	0.000248	CcSEcCtD
Doxepin—Nausea—Paclitaxel—lung cancer	5.71e-05	0.000247	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—lung cancer	5.71e-05	0.000247	CcSEcCtD
Doxepin—Amitriptyline—ALB—lung cancer	5.69e-05	0.028	CrCbGaD
Doxepin—Hyperhidrosis—Methotrexate—lung cancer	5.68e-05	0.000246	CcSEcCtD
Doxepin—Malaise—Doxorubicin—lung cancer	5.62e-05	0.000243	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—lung cancer	5.6e-05	0.000243	CcSEcCtD
Doxepin—Anorexia—Methotrexate—lung cancer	5.6e-05	0.000243	CcSEcCtD
Doxepin—Syncope—Doxorubicin—lung cancer	5.59e-05	0.000242	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—lung cancer	5.58e-05	0.000242	CcSEcCtD
Doxepin—Diarrhoea—Docetaxel—lung cancer	5.58e-05	0.000242	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—lung cancer	5.51e-05	0.000239	CcSEcCtD
Doxepin—Hypotension—Methotrexate—lung cancer	5.49e-05	0.000238	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—lung cancer	5.48e-05	0.000237	CcSEcCtD
Doxepin—Imipramine—ABCB1—lung cancer	5.46e-05	0.0269	CrCbGaD
Doxepin—Cough—Doxorubicin—lung cancer	5.44e-05	0.000236	CcSEcCtD
Doxepin—Amitriptyline—ABCB1—lung cancer	5.43e-05	0.0267	CrCbGaD
Doxepin—Convulsion—Doxorubicin—lung cancer	5.4e-05	0.000234	CcSEcCtD
Doxepin—Dizziness—Docetaxel—lung cancer	5.39e-05	0.000233	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—lung cancer	5.38e-05	0.000233	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—lung cancer	5.35e-05	0.000232	CcSEcCtD
Doxepin—Insomnia—Methotrexate—lung cancer	5.31e-05	0.00023	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—lung cancer	5.31e-05	0.00023	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—lung cancer	5.31e-05	0.00023	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—lung cancer	5.31e-05	0.00023	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—lung cancer	5.29e-05	0.000229	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—lung cancer	5.28e-05	0.000229	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.27e-05	0.000228	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—lung cancer	5.24e-05	0.000227	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—lung cancer	5.24e-05	0.000227	CcSEcCtD
Doxepin—Somnolence—Methotrexate—lung cancer	5.22e-05	0.000226	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—lung cancer	5.19e-05	0.000225	CcSEcCtD
Doxepin—Vomiting—Docetaxel—lung cancer	5.18e-05	0.000224	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—lung cancer	5.17e-05	0.000224	CcSEcCtD
Doxepin—Rash—Docetaxel—lung cancer	5.14e-05	0.000223	CcSEcCtD
Doxepin—Dermatitis—Docetaxel—lung cancer	5.14e-05	0.000222	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—lung cancer	5.13e-05	0.000222	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—lung cancer	5.11e-05	0.000221	CcSEcCtD
Doxepin—Headache—Docetaxel—lung cancer	5.11e-05	0.000221	CcSEcCtD
Doxepin—Oedema—Doxorubicin—lung cancer	5.09e-05	0.00022	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—lung cancer	5.07e-05	0.00022	CcSEcCtD
Doxepin—Fatigue—Methotrexate—lung cancer	5.07e-05	0.000219	CcSEcCtD
Doxepin—Infection—Doxorubicin—lung cancer	5.05e-05	0.000219	CcSEcCtD
Doxepin—Pain—Methotrexate—lung cancer	5.02e-05	0.000218	CcSEcCtD
Doxepin—Shock—Doxorubicin—lung cancer	5.01e-05	0.000217	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—lung cancer	4.99e-05	0.000216	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—lung cancer	4.98e-05	0.000216	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—lung cancer	4.97e-05	0.000215	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—lung cancer	4.94e-05	0.000214	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—lung cancer	4.92e-05	0.000213	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—lung cancer	4.85e-05	0.00021	CcSEcCtD
Doxepin—Nausea—Docetaxel—lung cancer	4.84e-05	0.00021	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—lung cancer	4.84e-05	0.00021	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—lung cancer	4.8e-05	0.000208	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—lung cancer	4.75e-05	0.000206	CcSEcCtD
Doxepin—Urticaria—Methotrexate—lung cancer	4.67e-05	0.000202	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—lung cancer	4.64e-05	0.000201	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—lung cancer	4.64e-05	0.000201	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.64e-05	0.000201	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—lung cancer	4.6e-05	0.000199	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—lung cancer	4.57e-05	0.000198	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—lung cancer	4.54e-05	0.000196	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—lung cancer	4.52e-05	0.000196	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—lung cancer	4.48e-05	0.000194	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—lung cancer	4.42e-05	0.000192	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—lung cancer	4.39e-05	0.00019	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—lung cancer	4.39e-05	0.00019	CcSEcCtD
Doxepin—Constipation—Doxorubicin—lung cancer	4.35e-05	0.000188	CcSEcCtD
Doxepin—Pain—Doxorubicin—lung cancer	4.35e-05	0.000188	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—lung cancer	4.33e-05	0.000187	CcSEcCtD
Doxepin—Asthenia—Methotrexate—lung cancer	4.22e-05	0.000183	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—lung cancer	4.19e-05	0.000182	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—lung cancer	4.16e-05	0.00018	CcSEcCtD
Doxepin—Pruritus—Methotrexate—lung cancer	4.16e-05	0.00018	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—lung cancer	4.04e-05	0.000175	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—lung cancer	4.02e-05	0.000174	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—lung cancer	4.02e-05	0.000174	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—lung cancer	4.02e-05	0.000174	CcSEcCtD
Doxepin—Dizziness—Methotrexate—lung cancer	3.89e-05	0.000168	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—lung cancer	3.75e-05	0.000162	CcSEcCtD
Doxepin—Vomiting—Methotrexate—lung cancer	3.74e-05	0.000162	CcSEcCtD
Doxepin—Rash—Methotrexate—lung cancer	3.7e-05	0.00016	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—lung cancer	3.7e-05	0.00016	CcSEcCtD
Doxepin—Headache—Methotrexate—lung cancer	3.68e-05	0.000159	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—lung cancer	3.65e-05	0.000158	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—lung cancer	3.6e-05	0.000156	CcSEcCtD
Doxepin—Nausea—Methotrexate—lung cancer	3.49e-05	0.000151	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—lung cancer	3.48e-05	0.000151	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—lung cancer	3.36e-05	0.000146	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—lung cancer	3.23e-05	0.00014	CcSEcCtD
Doxepin—Rash—Doxorubicin—lung cancer	3.21e-05	0.000139	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—lung cancer	3.2e-05	0.000139	CcSEcCtD
Doxepin—Headache—Doxorubicin—lung cancer	3.19e-05	0.000138	CcSEcCtD
Doxepin—Nausea—Doxorubicin—lung cancer	3.02e-05	0.000131	CcSEcCtD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	2.57e-06	1.95e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—lung cancer	2.57e-06	1.95e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—lung cancer	2.56e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—lung cancer	2.56e-06	1.95e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—lung cancer	2.56e-06	1.95e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—lung cancer	2.56e-06	1.94e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—lung cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—lung cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—lung cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—lung cancer	2.55e-06	1.93e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—lung cancer	2.54e-06	1.93e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—lung cancer	2.54e-06	1.93e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—lung cancer	2.53e-06	1.93e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—lung cancer	2.53e-06	1.92e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—lung cancer	2.53e-06	1.92e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—lung cancer	2.53e-06	1.92e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—lung cancer	2.52e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK3—lung cancer	2.52e-06	1.91e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—lung cancer	2.52e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.51e-06	1.91e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TYMS—lung cancer	2.51e-06	1.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—lung cancer	2.51e-06	1.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—lung cancer	2.5e-06	1.9e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.5e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—lung cancer	2.49e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—lung cancer	2.49e-06	1.89e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—lung cancer	2.48e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—lung cancer	2.48e-06	1.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.48e-06	1.88e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—lung cancer	2.48e-06	1.88e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.48e-06	1.88e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CD—lung cancer	2.47e-06	1.88e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—lung cancer	2.47e-06	1.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—lung cancer	2.47e-06	1.88e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	2.46e-06	1.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—lung cancer	2.46e-06	1.87e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—lung cancer	2.46e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—lung cancer	2.45e-06	1.87e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CD—lung cancer	2.45e-06	1.86e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—lung cancer	2.45e-06	1.86e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—lung cancer	2.45e-06	1.86e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—lung cancer	2.44e-06	1.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—lung cancer	2.44e-06	1.85e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—lung cancer	2.43e-06	1.85e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—lung cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—lung cancer	2.41e-06	1.83e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—lung cancer	2.41e-06	1.83e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.41e-06	1.83e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.4e-06	1.82e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—lung cancer	2.39e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—lung cancer	2.39e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.39e-06	1.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—lung cancer	2.39e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—lung cancer	2.39e-06	1.81e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—lung cancer	2.38e-06	1.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—lung cancer	2.38e-06	1.81e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—lung cancer	2.38e-06	1.81e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.37e-06	1.8e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—lung cancer	2.37e-06	1.8e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—lung cancer	2.37e-06	1.8e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—lung cancer	2.36e-06	1.79e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—lung cancer	2.35e-06	1.79e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—lung cancer	2.35e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—lung cancer	2.35e-06	1.79e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP1A1—lung cancer	2.35e-06	1.79e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—lung cancer	2.35e-06	1.78e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CB—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—lung cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—lung cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—lung cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—lung cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ERCC2—lung cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—lung cancer	2.32e-06	1.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.32e-06	1.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—lung cancer	2.32e-06	1.77e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—lung cancer	2.32e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—lung cancer	2.32e-06	1.76e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—lung cancer	2.31e-06	1.75e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—lung cancer	2.3e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—lung cancer	2.3e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—lung cancer	2.3e-06	1.75e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CB—lung cancer	2.29e-06	1.74e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK3—lung cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—lung cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—lung cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—lung cancer	2.27e-06	1.73e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—lung cancer	2.27e-06	1.72e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—lung cancer	2.26e-06	1.72e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.25e-06	1.71e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK3—lung cancer	2.24e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—lung cancer	2.23e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK3—lung cancer	2.23e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK3—lung cancer	2.23e-06	1.69e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—lung cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—lung cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—lung cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CREBBP—lung cancer	2.21e-06	1.68e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK3—lung cancer	2.2e-06	1.68e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK3—lung cancer	2.2e-06	1.67e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—lung cancer	2.2e-06	1.67e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—lung cancer	2.18e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—lung cancer	2.18e-06	1.66e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—lung cancer	2.18e-06	1.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—lung cancer	2.17e-06	1.65e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—lung cancer	2.17e-06	1.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—lung cancer	2.17e-06	1.65e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—lung cancer	2.16e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.16e-06	1.64e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CB—lung cancer	2.16e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—lung cancer	2.15e-06	1.63e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.15e-06	1.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—lung cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—lung cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—lung cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CB—lung cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—lung cancer	2.14e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—lung cancer	2.14e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—lung cancer	2.14e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.13e-06	1.62e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—lung cancer	2.13e-06	1.62e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—lung cancer	2.12e-06	1.62e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—lung cancer	2.12e-06	1.61e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—lung cancer	2.12e-06	1.61e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—lung cancer	2.1e-06	1.59e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CD—lung cancer	2.1e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—lung cancer	2.09e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—lung cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—lung cancer	2.07e-06	1.57e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—lung cancer	2.07e-06	1.57e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—lung cancer	2.06e-06	1.56e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—lung cancer	2.05e-06	1.56e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	2.04e-06	1.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.04e-06	1.55e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—lung cancer	2.03e-06	1.54e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—lung cancer	2.03e-06	1.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—lung cancer	2.02e-06	1.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—lung cancer	2.02e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—lung cancer	2.02e-06	1.53e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—lung cancer	2.01e-06	1.53e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—lung cancer	2.01e-06	1.53e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—lung cancer	2.01e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—lung cancer	2.01e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—lung cancer	2e-06	1.52e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—lung cancer	1.99e-06	1.51e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—lung cancer	1.99e-06	1.51e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—lung cancer	1.98e-06	1.51e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—lung cancer	1.98e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—lung cancer	1.98e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.98e-06	1.5e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—lung cancer	1.98e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—lung cancer	1.97e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.94e-06	1.48e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—lung cancer	1.93e-06	1.47e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.92e-06	1.46e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—lung cancer	1.9e-06	1.44e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.89e-06	1.44e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—lung cancer	1.89e-06	1.44e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—lung cancer	1.89e-06	1.43e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.88e-06	1.43e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—lung cancer	1.86e-06	1.42e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.85e-06	1.41e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.85e-06	1.41e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—lung cancer	1.85e-06	1.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—lung cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—lung cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CB—lung cancer	1.83e-06	1.39e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—lung cancer	1.82e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.82e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.82e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.82e-06	1.38e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—lung cancer	1.81e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—lung cancer	1.81e-06	1.38e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—lung cancer	1.8e-06	1.37e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—lung cancer	1.79e-06	1.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—lung cancer	1.79e-06	1.36e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—lung cancer	1.78e-06	1.36e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—lung cancer	1.78e-06	1.35e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—lung cancer	1.78e-06	1.35e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—lung cancer	1.76e-06	1.34e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—lung cancer	1.76e-06	1.34e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—lung cancer	1.76e-06	1.34e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—lung cancer	1.75e-06	1.33e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—lung cancer	1.75e-06	1.33e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—lung cancer	1.74e-06	1.33e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—lung cancer	1.74e-06	1.33e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—lung cancer	1.72e-06	1.3e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—lung cancer	1.71e-06	1.3e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—lung cancer	1.71e-06	1.3e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CREBBP—lung cancer	1.71e-06	1.3e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—lung cancer	1.7e-06	1.29e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.7e-06	1.29e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.69e-06	1.28e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—lung cancer	1.68e-06	1.28e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.68e-06	1.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.67e-06	1.27e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—lung cancer	1.67e-06	1.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—lung cancer	1.65e-06	1.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—lung cancer	1.64e-06	1.25e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—lung cancer	1.64e-06	1.25e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—lung cancer	1.63e-06	1.24e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—lung cancer	1.63e-06	1.24e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—lung cancer	1.63e-06	1.24e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CD—lung cancer	1.62e-06	1.23e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—lung cancer	1.61e-06	1.23e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—lung cancer	1.61e-06	1.22e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—lung cancer	1.6e-06	1.21e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—lung cancer	1.58e-06	1.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.56e-06	1.19e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—lung cancer	1.54e-06	1.17e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—lung cancer	1.51e-06	1.15e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—lung cancer	1.51e-06	1.15e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—lung cancer	1.51e-06	1.15e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—lung cancer	1.51e-06	1.14e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—lung cancer	1.5e-06	1.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—lung cancer	1.49e-06	1.14e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—lung cancer	1.49e-06	1.13e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.48e-06	1.13e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—lung cancer	1.43e-06	1.09e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CB—lung cancer	1.41e-06	1.07e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—lung cancer	1.4e-06	1.06e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—lung cancer	1.39e-06	1.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.38e-06	1.05e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—lung cancer	1.31e-06	9.99e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—lung cancer	1.3e-06	9.91e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—lung cancer	1.22e-06	9.26e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—lung cancer	1.17e-06	8.88e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—lung cancer	1.16e-06	8.83e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—lung cancer	1.14e-06	8.66e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—lung cancer	1.11e-06	8.47e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—lung cancer	1.07e-06	8.16e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—lung cancer	1.06e-06	8.09e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—lung cancer	9.1e-07	6.92e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—lung cancer	8.59e-07	6.53e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—lung cancer	7.02e-07	5.34e-06	CbGpPWpGaD
